019175.KS · 신풍제약우

South Korea · RS rating 60 · As of 2026-10-14

Price14,500.00 KRW
1-day change+1.3%
RS rating (overall / 1M / 3M / 12M)60 / 68 / 78 / 18
StageDeclining
Composite / Minervini / CANSLIM score27 / 20 / 21
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-2633.3%
Sales growth Q/Q+17.2%
Distance from 52-week high+48.4%
Market cap (USD)$555.4M
Open South Korea in the interactive screener